These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12549957)

  • 21. Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure.
    Colbert K; Greene MH
    Crit Care Nurs Q; 2003; 26(1):40-4. PubMed ID: 12669946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of nesiritide on renal function and mortality in patients suffering from heart failure.
    Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting.
    Feldman DS; Sun B
    Heart Fail Rev; 2004 Jul; 9(3):203-8. PubMed ID: 15809818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nesiritide for the treatment of decompensated heart failure.
    Colucci WS
    J Card Fail; 2001 Mar; 7(1):92-100. PubMed ID: 11264555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.
    Fonarow GC
    Heart Fail Rev; 2003 Oct; 8(4):321-5. PubMed ID: 14574051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
    Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
    JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nesiritide: a unique therapeutic cardiac peptide.
    Rayburn BK; Bourge RC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S25-31. PubMed ID: 12439359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.
    Hiestand B; Abraham WT
    Curr Cardiol Rep; 2007 May; 9(3):182-6. PubMed ID: 17470330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
    Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
    J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Xiong B; Wang C; Yao Y; Huang Y; Tan J; Cao Y; Zou Y; Huang J
    PLoS One; 2015; 10(6):e0131326. PubMed ID: 26107522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.
    Strain WD
    Int J Clin Pract; 2004 Nov; 58(11):1081-7. PubMed ID: 15605677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.